Dr. Feldstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8110 Birmingham Way
Bldg 28
San Diego, CA 92123Phone+1 858-966-4003Fax+1 858-560-6798
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pediatric Gastroenterology, 2001 - 2004
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Pediatrics, 1998 - 2001
- University of Buenos AiresClass of 1997
Certifications & Licensure
- CA State Medical License 2011 - 2025
- OH State Medical License 2004 - 2013
- MN State Medical License 2001 - 2004
Publications & Presentations
PubMed
- Correlating neighborhood-level deprivation and pediatric metabolic dysfunction-associated steatotic liver disease.Nicole E Hickman, Mason Price, Noe C Crespo, Ariel E Feldstein
Journal of Pediatric Gastroenterology and Nutrition. 2024-06-01 - 1 citationsCell Death in Liver Disease and Liver Surgery.Christian Stoess, Yeon-Kyung Choi, Janset Onyuru, Helmut Friess, Hal M Hoffman
Biomedicines. 2024-03-01 - 1 citationsNLRP3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis.Benedikt Kaufmann, Aleksandra Leszczynska, Agustina Reca, Laela M Booshehri, Janset Onyuru
EMBO Reports. 2024-01-01
Journal Articles
- Non‐Alcoholic Fatty Liver Disease in Pediatric Type 2 Diabetes: Metabolic and Histologic Characteristics in 38 SubjectsRon S Newfield, Ariel E Feldstein, Jeffrey B Schwimmer, Robert O Newbury, Daphne S Say, Pediatric Diabetes
- Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic SteatohepatitisRohit Loomba, Ariel E Feldstein, The Journal of Immunology
- Fatty Liver in Adolescents: Mechanisms, Clinical Features and TherapyAriel Feldstein, MD, Journal of Hepatology
Press Mentions
- Genentech Acquires Jecure TherapeuticsNovember 27th, 2018
- Young, Fat and Facing Liver Disease: As Obesity Rates Climb, Fatty Livers Are Emerging as a Serious Threat to Children’s HealthMay 16th, 2018
- Versant Ventures Launches Jecure TherapeuticsDecember 14th, 2017
- Join now to see all
Grant Support
- Exploratory Project: 1 Mitochondrial Phospholipid Oxidation In Alcoholic LiverNational Institute On Alcohol Abuse And Alcoholism2009–2011
- Caspase Dependent Cell Death In Nonalcoholic Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- The Lysosomal-Mitochondrial Axis In Nonalcoholic Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: